ArticleTobacco use insights2026
Beliefs About e-Cigarette Regulation Among a Cohort of Long-Term Adult Users: A Thematic Analysis.
Article in Tobacco use insights, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Introduction: The United States Food and Drug Administration (FDA) is a regulatory authority with the ability to regulate tobacco products, including electronic cigarettes (e-cigarettes). Few studies have investigated the beliefs and attitudes about e-cigarette regulation, from the perspective of long-term users of e-cigarettes. The purpose of the current study was to understand the beliefs about e-cigarette regulation among former and current users of e-cigarettes using a qualitative approach. Methods: We conducted a cross-sectional survey among a cohort of former and current users of e-cigarettes in 2022 which contained open-ended questions about perceptions of e-cigarette regulation. Participants were asked about their e-cigarette use, whether the FDA should regulate e-cigarettes (yes/no), and responded to an open-ended question about their opinions of FDA regulation/non-regulation of e-cigarettes. Means and frequencies were used to describe the sample, and all open-ended responses were imported into MAXQDA software. Open-ended responses were analyzed using thematic analysis. Results: Participants (n=172) were 93.0% White, 66.3% male, and 73.3% were people who currently use e-cigarettes. More than half (51.7%) of participants reported they do not believe the FDA should regulate e-cigarettes, while 48.3% of participants reported they believe that the FDA should regulate e-cigarettes. Opponents of e-cigarette regulation felt it would lead to over-regulation and politicization. On the other hand, those with supportive views felt that FDA regulation would ensure the safety of e-cigarette products. Conclusion: Our findings suggest that this cohort of long -term users of e-cigarettes believe FDA regulation will affect the availability of e-cigarette products, making it harder to quit smoking or to avoid relapsing to traditional cigarettes. User perceptions highlighted that the FDA should assess the health impact of e-cigarette products and their influence on smoking cessation efforts among smokers who had otherwise been unable to quit.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.